In many cancers, high levels of anti-apoptotic proteins such as BCL-2 and BCL-XL were shown to contribute not only to tumor initiation and progression, but also to lack of response to chemotherapy [5, 6]. This evidence concerns the gene BCL2L1 and neoplasm.